Clinical trials
Phase 2 Parkinson Disease trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| St. Joseph's Hospital and Medical Center, Phoenix | 2 |
| Tel-Aviv Sourasky Medical Center | 2 |
| University College, London | 2 |
| 1st Hospital of Social Security Services | 1 |
| Amarantus BioScience Holdings, Inc. | 1 |
| B&A Therapeutics | 1 |
| Beijing Pins Medical Co., Ltd | 1 |
| Center for Neurology, Stockholm | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 50 |
| Anxiety Disorders | 3 |
| Dementia | 3 |
| Cognitive Dysfunction | 2 |
| Tremor | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Anemia, Sickle Cell | 1 |
| Autistic Disorder | 1 |
| Bipolar Disorder | 1 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.